Market revenue in 2023 | USD 661.8 million |
Market revenue in 2030 | USD 1,102.3 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Transdermal patches |
Fastest growing segment | Photodynamic Therapy Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Photodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters |
Key market players worldwide | Abbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.
Transdermal patches was the largest segment with a revenue share of 23.18% in 2023. Horizon Databook has segmented the Saudi Arabia drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.
An increase in the demand for minimally invasive surgical procedures and advancements in drug-device combination products are expected to positively impact the market in Saudi Arabia. The growing incidence of cancer can be attributed to major changes in socioeconomic factors. Changes in lifestyle due to Westernization include increased consumption of processed food and sedentary behavior.
These lifestyle changes are likely to be responsible for the increase in the incidence of several diseases, including cancer. However, due to low awareness, the adoption of drug-device combination products is less in the country, which may restrict the market growth. In Saudi Arabia's drug-device combination products market, a competitive environment is developing as companies focus on technological innovations and market penetration strategies.
Companies are focusing on continuous innovation and introducing advanced products specifically designed for Saudi Arabia's healthcare needs.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account